MiMedx Group Inc
-
Ticker
MDXG
-
Industry
--None-- More
-
Sector
Healthcare More
- 501-1000 Employees
- Based in Marietta, Georgia
MiMedx Group, Inc. develops, processes, and markets patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. Its biomaterial platform technologies are AmnioFix, EpiFix, and CollaFix. The company’s AmnioFix and EpiFix are tissue technologies processed from human amniotic membrane derived from donated placentas.
REPORT RATINGS
4.8 / 5.0 (122)
MiMedx Group Inc reports have an aggregate usefulness score of 4.8 based on 122 reviews.
MiMedx Group Inc
Most Recent Annual Report
MOST RECENT
2023 Annual Report and Form 10K
Older/Archived Annual Reports